|
|
| (11) | Liudijimo numeris | C 4455 |
| (68) | Patento numeris | 4455 |
| (21) | Paraiškos papildomos apsaugos liudijimui gauti numeris | PA 2005 007 |
| (22) | Paraiškos papildomos apsaugos liudijimui gauti padavimo data | 2005-08-19 |
| (41) | Paraiškos papildomos apsaugos liudijimui gauti paskelbimo data | 2005-10-25 |
| Liudijimo paskelbimo data | 2006-09-25 | |
| (24) | Liudijimo įsigaliojimo data | 2016-05-23 |
| (71) |
TEVA PHARMACEUTICAL INDUSTRIES, LTD.,
Science Based Industries Campus, Har Hotzvim, P. O. Box 1142, 91010 Jerusalem,
IL
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD., Senate House, Technion City, 32000 Haifa, IL |
| (73) |
TEVA PHARMACEUTICAL INDUSTRIES, LTD.,
Science Based Industries Campus, Har Hotzvim, P. O. Box 1142, 91010 Jerusalem,
IL
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD., Senate House, Technion City, 32000 Haifa, IL |
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (93) | EU//1/04/304/001, EU//1/04/304/002, EU//1/04/304/003, EU//1/04/304/004, EU//1/04/304/005, EU//1/04/304/006, EU//1/04/304/007, 2005-02-21 |
| (94) | 2020-02-22 |
| (95) | Rasagilinum (N-propargil-1-(R)-aminoindano mezilatas) |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2019-04-23 | 4 | 347.00 EUR |
| PAL galiojimo terminas pasibaigęs |